RxSight, Inc. (RXST) CEO Aziz Mottiwala identified as insider in Form 3

Rhea-AI Filing Summary

RxSight, Inc. filed an initial Form 3 identifying Aziz Mottiwala as a reporting person in his roles as President and CEO and as a director. The filing does not list any equity holdings or transactions for him, and includes a reference to an Exhibit 24 Power of Attorney.

Key Figures

Reported transactions: 0 Holding entries: 0

2 metrics

Reported transactions 0 Form 3 transaction summary shows no buy, sell, or derivative transactions

Holding entries 0 Initial Form 3 lists no specific equity holdings for the reporting person

Key Terms

Form 3, Power of Attorney, reporting person

3 terms

Form 3 regulatory

"filed an initial Form 3 identifying Aziz Mottiwala as a reporting person"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Power of Attorney regulatory

"remarks reference an Exhibit 24 Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

reporting person regulatory

"identifying Aziz Mottiwala as a reporting person in his roles"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/24/2026 - 08:06 PM Accepted by SEC EDGAR 07/24/2026 - 08:05 PM Learn about SEC filing dates

FAQ

What does the RxSight (RXST) Form 3 for Aziz Mottiwala disclose?

The Form 3 identifies Aziz Mottiwala as a reporting person of RxSight (RXST) in his roles as President and CEO and director, but it does not report any equity transactions or holdings.

Does Aziz Mottiwala report any RxSight (RXST) share transactions in this Form 3?

No transactions are reported. The Form 3 transaction summary shows 0 buy, 0 sell, and 0 derivative transactions, indicating this filing is purely an initial ownership statement without trade activity.

Are any RxSight (RXST) share holdings listed for Aziz Mottiwala in this Form 3?

The filing lists 0 holding entries, meaning no specific RxSight (RXST) share positions are detailed for Aziz Mottiwala in this initial Form 3 submission.

What is Aziz Mottiwala’s role at RxSight (RXST) according to the Form 3?

Aziz Mottiwala is reported as both President and CEO and a director of RxSight (RXST), making him an officer and director-level reporting person under SEC beneficial ownership rules.

What does the Power of Attorney reference mean in the RxSight (RXST) Form 3?

The remarks reference an Exhibit 24 Power of Attorney, indicating a document authorizing another party to sign or act on behalf of the reporting person for certain SEC-related matters.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mottiwala Aziz

(Last) (First) (Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO CALIFORNIA 92656

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/20/2026

3. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Jim Schindler, as Attorney-in-Fact	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)